NEUROCRINE BIOSCIENCES INC Other Non-Current Assets
NEUROCRINE BIOSCIENCES INC (NBIX) had Other Non-Current Assets of $59.30 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-31
- 2026-06-30: Other Assets, Noncurrent $59.30M.
- 2026-03-31: Other Assets, Noncurrent $73.60M.
- 2025-12-31: Other Assets, Noncurrent $48.70M; Other Assets, Noncurrent as first filed $59.50M.
- 2025-09-30: Other Assets, Noncurrent $20.30M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $59.30M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $73.60M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $48.70M 10-Q · filed 2026-07-31 | $59.50M 10-K · filed 2026-02-11 |
| 2025-09-30 | $20.30M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $21.60M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $15.30M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $52.00M 10-K · filed 2026-02-11 | $15.50M 10-K · filed 2025-02-10 |
| 2024-09-30 | $61.60M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $57.80M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $50.90M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $49.60M 10-K · filed 2025-02-10 | |
| 2023-09-30 | $43.10M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $35.90M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $24.90M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $25.00M 10-K · filed 2024-02-09 | |
| 2022-09-30 | $10.50M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $10.10M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $4.40M 10-K · filed 2023-02-09 | |
| 2021-09-30 | $3.20M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $3.20M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $1.40M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $6.40M 10-K · filed 2022-02-11 | $3.20M 10-K · filed 2021-02-05 |
| 2020-09-30 | $3.40M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.60M 10-Q · filed 2020-08-03 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |